Study of a complexation process between naltrexone and Eudragit(R) L as an oral controlled release system

被引:9
作者
AlvarezFuentes, J
Caraballo, I
Boza, A
Llera, JM
Holgado, MA
FernandezArevalo, M
机构
[1] UNIV SEVILLA,FAC FARM,DEPT QUIM ORGAN & FARMACEUT,E-41012 SEVILLE,SPAIN
[2] CTR QUIM FARMACEUT,DEPT SINTESIS QUIM,HAVANA,CUBA
关键词
naltrexone hydrochloride; Eudragit(R) L30D; preformulation; controlled release complex;
D O I
10.1016/S0378-5173(96)04849-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymeric complexes based on the interaction between Eudragit(R) L and naltrexone hydrochloride were elaborated. A preformulation study of the drug was designed to address the following points: (a) the development of two alternative methods (high performance liquid chromatography (HPLC) and UV spectrophotometry) for the analysis and quantifying of naltrexone; (b) the determination of the aqueous solubility of naltrexone hydrochloride; and (c) the characterization of naltrexone hydrochloride from the following points of view: morphological (scanning electronic microscopy, SEM), thermal (differential scanning calorimetry, DSC and hot stage-microscopy, HSM) and spectroscopical (H-1- and C-13-nuclear magnetic resonance, NMR). Furthermore, some of these thechniques were used for the physical and chemical characterization of naltrexone polymeric complexes. An interaction by means of hydrogen bonds between the polymer and naltrexone was demonstrated using NMR spectroscopic techniques. The in vitro release of naltrexone-Eudragit(R) L complex using a pH gradient technique was studied. A significant reduction in the release rate of drug from the complex used as naltrexone controlled release system as well as a very high efficiency in the dissolution process have been found. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:219 / 230
页数:12
相关论文
共 20 条
[1]   MORPHINE POLYMERIC COPRECIPITATES FOR CONTROLLED-RELEASE - ELABORATION AND CHARACTERIZATION [J].
ALVAREZFUENTES, J ;
FERNANDEZAREVALO, M ;
HOLGADO, MA ;
CARABALLO, I ;
LLERA, JM ;
RABASCO, AM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (15) :2409-2424
[2]  
ALVAREZFUENTES J, 1994, PHARMAZIE, V49, P834
[3]  
BLUMBERG H, 1974, NARCOTIC ANTAGONISTS, V8, P33
[4]   COMMON ION EQUILIBRIA OF HYDROCHLORIDE SALTS AND THE SETSCHENOW EQUATION [J].
BOGARDUS, JB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (05) :588-590
[5]   COMPATIBILITY STUDY BETWEEN ATENOLOL AND TABLET EXCIPIENTS USING DIFFERENTIAL SCANNING CALORIMETRY [J].
BOTHA, SA ;
LOTTER, AP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (12) :1945-1954
[6]  
Breitmaier E., 1987, Carbon-13 NMR spectroscopy
[7]  
ELEGAKEY AM, 1982, PHARM ACTA HELV, V57, P236
[8]  
FERNANDEZAREVAL.M, 1994, P 13 PHARM TECHN C S, V3, P158
[9]  
FLORENCE AT, 1988, PHYSICOCHEMICAL PRIN, P141
[10]  
FORD JL, 1989, PHARM THERMAL ANAL, P25